Authors: KINGSTON AE ORNSTEIN PL WRIGHT RA JOHNSON BG MAYNE NG BURNETT JP BELAGAJE R WU S SCHOEPP DD

Citation: Ae. Kingston et al., LY341495 IS A NANOMOLAR POTENT AND SELECTIVE ANTAGONIST OF GROUP-II METABOTROPIC GLUTAMATE RECEPTORS, Neuropharmacology, 37(1), 1998, pp. 1-12

Authors: DELAPP N WU S BELAGAJE R JOHNSTONE E LITTLE S SHANNON H BYMASTER F CALLIGARO D MITCH C WHITESITT C WARD J SHEARDOWN M FINKJENSEN A JEPPESEN L THOMSEN C SAUERBERG P

Citation: N. Delapp et al., EFFECTS OF THE M1 AGONIST XANOMELINE ON PROCESSING OF HUMAN BETA-AMYLOID PRECURSOR PROTEIN (FAD, SWEDISH MUTANT) TRANSFECTED INTO CHINESE-HAMSTER OVARY-M1 CELLS, Biochemical and biophysical research communications, 244(1), 1998, pp. 156-160

Authors: SCHOEPP DD SALHOFF CR WRIGHT RA JOHNSON BG BURNETT JP MAYNE NG BELAGAJE R WU S MONN JA

Citation: Dd. Schoepp et al., THE NOVEL METABOTROPIC GLUTAMATE-RECEPTOR AGONIST 2R,4R-APDC POTENTIATES STIMULATION OF PHOSPHOINOSITIDE HYDROLYSIS IN THE RAT HIPPOCAMPUS BY 3,5-DIHYDROXYPHENYLGLYCINE - EVIDENCE FOR A SYNERGISTIC INTERACTIONBETWEEN GROUP-1 AND GROUP-2 RECEPTORS, Neuropharmacology, 35(12), 1996, pp. 1661-1672